![](/img/cover-not-exists.png)
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma
Lori M. Minasian, Tzy Jyun Yao, Thomas A. Steffens, David A. Scheinberg, Linda Williams, Elyn Riedel, Alan N. Houghton, Paul B. ChapmanVolume:
75
Year:
1995
Language:
english
Pages:
7
DOI:
10.1002/1097-0142(19950501)75:93.0.co;2-f
File:
PDF, 647 KB
english, 1995